153 related articles for article (PubMed ID: 2959197)
1. Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
Van der Auwera P; Klastersky J
Antimicrob Agents Chemother; 1987 Jul; 31(7):1002-5. PubMed ID: 2959197
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
Van der Auwera P; Klastersky J
J Antimicrob Chemother; 1987 May; 19(5):623-35. PubMed ID: 2956228
[TBL] [Abstract][Full Text] [Related]
3. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
Hackbarth CJ; Chambers HF; Sande MA
Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
Odenholt I; Löwdin E; Cars O
Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.
Lagast H; Dodion P; Klastersky J
J Antimicrob Chemother; 1986 Oct; 18(4):513-20. PubMed ID: 2945811
[TBL] [Abstract][Full Text] [Related]
7. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
[TBL] [Abstract][Full Text] [Related]
8. Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model.
Tuazon CU; Washburn D
J Antimicrob Chemother; 1987 Aug; 20(2):233-7. PubMed ID: 2959643
[TBL] [Abstract][Full Text] [Related]
9. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
Barr JG; Smyth ET; Hogg GM
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
[TBL] [Abstract][Full Text] [Related]
12. Protein binding and serum bactericidal activities of vancomycin and teicoplanin.
Dykhuizen RS; Harvey G; Stephenson N; Nathwani D; Gould IM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1842-7. PubMed ID: 7486929
[TBL] [Abstract][Full Text] [Related]
13. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Low DE; McGeer A; Poon R
Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods.
Hershberger E; Aeschlimann JR; Moldovan T; Rybak MJ
Antimicrob Agents Chemother; 1999 Mar; 43(3):717-21. PubMed ID: 10049300
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
Van der Auwera P; Klastersky J
Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fosfomycin and teicoplanin in serum bactericidal activity against staphylococci.
Vogt K; Rauhut A; Trautmann M; Hahn H
Arzneimittelforschung; 1995 Aug; 45(8):894-7. PubMed ID: 7575756
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model.
Pallanza R; Scotti R; Arioli V
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():15-21. PubMed ID: 2965127
[TBL] [Abstract][Full Text] [Related]
19. Antistaphylococcal activity of rifampin with other antibiotics.
Zinner SH; Lagast H; Klastersky J
J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
[TBL] [Abstract][Full Text] [Related]
20. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
Bergeret M; Boutros N; Raymond J
Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
